Pay in 4 interest-free payments of $5.76 Learn more
Ships within 48 hours · Estimated delivery Nov 6 - Nov 11
Novo Nordisk argued that the unusually long administrative delay at INPI warranted a compensatory patent term extension that would have pushed competitor market entry well past 2026
Affordability and Access Barriers The high cost of GLP-1 drugs remains a critical issue , with monthly list prices reported as follows: Wegovy : $1,350 Zepbound : $1,060 (Source: Institute for Clinical and Economic Review) Because long-term use is generally required to maintain weight loss, the financial burden on health plans is substantial
And that's the best comparator
If you are dealing with this, it helps to know that these symptoms have a biological explanation, and that there are reasonable everyday steps that may ease them
(Lausanne) 10 , 577 (2019)
US$ 22.14
US$ 28.18
US$ 21.84
US$ 25.56
US$ 29.90
US$ 24.95
US$ 20.85
US$ 24.25
US$ 20.60
US$ 24.54
